CRTC denies FairPlay Canada's application on piracy websites on jurisdictional grounds
OTTAWA and GATINEAU, QC, Oct. 2, 2018 /CNW/ - The CRTC today denied FairPlay Canada's application to implement a proposed website-blocking regime to address copyright piracy because it does not have the jurisdiction under the Telecommunications Act. As such, the CRTC did not consider the merits of the proposal.
FairPlay Canada had requested that the CRTC create a regime that would identify websites and online services that are engaged in copyright piracy and require Internet service providers to block access to those websites and services.
Copyright piracy causes harm to the Canadian broadcasting system and the economy. The CRTC is of the view, however, that other avenues are more suitable to address this issue, which include the ongoing parliamentary review of the Copyright Act, as well as the expert panel review of the Telecommunications Act and the Broadcasting Act.
Quick Facts
Copyright piracy generally refers to the distribution or use of content without the copyright holder's consent and without payment.
The Copyright Act provides a regime to deal with copyright issues, and Parliament has not granted copyright jurisdiction to the CRTC through the Telecommunications Act.
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...
H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $64 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to acquire CGH Group S.A. ("CGH" or the "Company"), a...
Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing its interim report for January-June on Friday 19 July 2024 at 07.30 CET.
Alan Mamedi, CEO and Odd Bolin, CFO presents the report and...
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...